Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.7296 +0.0211 (+2.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about SciSparc Ltd. - Ordinary Shares < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds February 27, 2024 Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents February 21, 2024 SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health. Via Benzinga Topics Intellectual Property Exposures Intellectual Property What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? February 20, 2024 SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds February 20, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Why Is SciSparc (SPRC) Stock Up 50% Today? January 24, 2024 News of an investment fund inking an equity purchase agreement with SciSparc is boosting underlying credibility and lifting SPRC stock. Via InvestorPlace Why Is SciSparc (SPRC) Stock Up 25% Today? December 13, 2023 With SciSparc announcing positive results stemming from its joint venture, the drug discovery implications are boosting SPRC stock. Via InvestorPlace What's Going On With SciSparc Ltd Stock? December 13, 2023 SciSparc Ltd. (NASDAQ: SPRC) shares are trading higher Wednesday. Via Benzinga Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 20, 2024 Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. Via Benzinga SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds February 20, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder January 29, 2024 From SciSparc Ltd Via GlobeNewswire Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. Via Benzinga Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 24, 2024 Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... Via Benzinga Crude Oil Rises Over 1%; DuPont Shares Plunge January 24, 2024 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why SciSparc Stock Is Lighting Up January 24, 2024 SciSparc Ltd. shares are trading higher Wednesday after the company announced that it has entered into a standby equity purchase agreement with YA II PN, Ltd., a fund managed by Yorkville Advisors... Via Benzinga Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales January 24, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.29% to 38,013.76 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement January 24, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million January 19, 2024 From SciSparc Ltd Via GlobeNewswire Why Is Clearmind (CMND) Stock Up 40% Today? January 10, 2024 The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing. Via InvestorPlace SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments January 04, 2024 From SciSparc Ltd Via GlobeNewswire Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments January 04, 2024 From Clearmind Medicine Inc. Via GlobeNewswire Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 13, 2023 Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700... Via Benzinga SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform December 13, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel December 07, 2023 From SciSparc Ltd Via GlobeNewswire Why Is Clearmind Medicine (CMND) Stock Up 50% Today? December 05, 2023 Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock. Via InvestorPlace Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Defense Dept. Funds Ketamine Study For PTSD Treatment Via Benzinga Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial December 01, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Adopts Limited Duration Shareholder Rights Plan November 28, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment November 28, 2023 From SciSparc Ltd Via GlobeNewswire EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders November 28, 2023 Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy. Via Benzinga What's Going On With SciSparc Shares Today? November 27, 2023 SciSparc Ltd (NASDAQ: SPRC) shares are trading lower Monday. The company announced results for MitoCareX Bio with its drug discovery platform. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.